These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33549583)

  • 1. Phonemic fluency quantity and quality: Comparing patients with PSP, Parkinson's disease and focal frontal and subcortical lesions.
    Foley JA; Niven EH; Abrahams S; Cipolotti L
    Neuropsychologia; 2021 Mar; 153():107772. PubMed ID: 33549583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phonemic Verbal Fluency and Midbrain Atrophy in Progressive Supranuclear Palsy.
    Luca A; Nicoletti A; Donzuso G; Terravecchia C; Cicero CE; D'Agate C; Rascuná C; Manna R; Mostile G; Zappia M
    J Alzheimers Dis; 2021; 80(4):1669-1674. PubMed ID: 33720901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics and progression of cognitive deficits in progressive supranuclear palsy vs. multiple system atrophy and Parkinson's disease.
    Fiorenzato E; Antonini A; Camparini V; Weis L; Semenza C; Biundo R
    J Neural Transm (Vienna); 2019 Nov; 126(11):1437-1445. PubMed ID: 31432258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pattern of verbal, visuospatial and procedural learning in Richardson variant of progressive supranuclear palsy in comparison to Parkinson's disease.
    Sitek EJ; Wieczorek D; Konkel A; Dąbrowska M; Sławek J
    Psychiatr Pol; 2017 Aug; 51(4):647-659. PubMed ID: 28987055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential patterns of internally generated responses in parkinsonian disorders.
    Tjokrowijoto P; Ceslis A; Sullivan JDO; Adam R; Mellick G; Silburn P; Robinson GA
    Neuropsychologia; 2020 Sep; 146():107569. PubMed ID: 32707163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levodopa modulates semantic fluency and uniqueness in non-demented patients with progressive supranuclear palsy.
    Ma J; Zhang G; Zhao Z; Chan P; Ye Z
    Brain Behav; 2024 Jul; 14(7):e3606. PubMed ID: 38945805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tomographic measurements of regional cerebral blood flow in progressive supranuclear palsy and Parkinson's disease.
    Defebvre L; Lecouffe P; Destée A; Houdart P; Steinling M
    Acta Neurol Scand; 1995 Sep; 92(3):235-41. PubMed ID: 7484078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychological follow up in patients with Parkinson's disease, striatonigral degeneration-type multisystem atrophy, and progressive supranuclear palsy.
    Soliveri P; Monza D; Paridi D; Carella F; Genitrini S; Testa D; Girotti F
    J Neurol Neurosurg Psychiatry; 2000 Sep; 69(3):313-8. PubMed ID: 10945805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy.
    Fiorenzato E; Weis L; Falup-Pecurariu C; Diaconu S; Siri C; Reali E; Pezzoli G; Bisiacchi P; Antonini A; Biundo R
    J Neural Transm (Vienna); 2016 Dec; 123(12):1435-1442. PubMed ID: 27334897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Santangelo G; Cuoco S; Pellecchia MT; Erro R; Barone P; Picillo M
    J Neurol; 2018 Nov; 265(11):2602-2613. PubMed ID: 30178175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of parkinsonian syndromes according to differences in executive functions.
    Lange KW; Tucha O; Alders GL; Preier M; Csoti I; Merz B; Mark G; Herting B; Fornadi F; Reichmann H; Vieregge P; Reiners K; Becker G; Naumann M
    J Neural Transm (Vienna); 2003 Sep; 110(9):983-95. PubMed ID: 12938023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychiatric and cognitive profile of early Richardson's syndrome, Progressive Supranuclear Palsy-parkinsonism and Parkinson's disease.
    Pellicano C; Assogna F; Cellupica N; Piras F; Pierantozzi M; Stefani A; Cerroni R; Mercuri B; Caltagirone C; Pontieri FE; Spalletta G
    Parkinsonism Relat Disord; 2017 Dec; 45():50-56. PubMed ID: 29037499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychological pattern of striatonigral degeneration: comparison with Parkinson's disease and progressive supranuclear palsy.
    Pillon B; Gouider-Khouja N; Deweer B; Vidailhet M; Malapani C; Dubois B; Agid Y
    J Neurol Neurosurg Psychiatry; 1995 Feb; 58(2):174-9. PubMed ID: 7876847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-model mapping of phonemic fluency.
    Cipolotti L; Xu T; Harry B; Mole J; Lakey G; Shallice T; Chan E; Nachev P
    Brain Commun; 2021; 3(4):fcab232. PubMed ID: 34693285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Striatal volume is related to phonemic verbal fluency but not to semantic or alternating verbal fluency in early Parkinson's disease.
    Ellfolk U; Joutsa J; Rinne JO; Parkkola R; Jokinen P; Karrasch M
    J Neural Transm (Vienna); 2014 Jan; 121(1):33-40. PubMed ID: 23913130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Semantic and phonemic verbal fluency in Parkinson's disease: Influence of clinical and demographic variables.
    Obeso I; Casabona E; Bringas ML; Alvarez L; Jahanshahi M
    Behav Neurol; 2012; 25(2):111-8. PubMed ID: 22530265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apraxia in Parkinson's disease, progressive supranuclear palsy, multiple system atrophy and neuroleptic-induced parkinsonism.
    Leiguarda RC; Pramstaller PP; Merello M; Starkstein S; Lees AJ; Marsden CD
    Brain; 1997 Jan; 120 ( Pt 1)():75-90. PubMed ID: 9055799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smaller and Denser Speech Graphs in Nondemented Patients with Progressive Supranuclear Palsy.
    Ma J; Zhang G; Sun X; Chan P; Ye Z
    Behav Neurol; 2023; 2023():3771601. PubMed ID: 37790602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced phonemic fluency in progressive supranuclear palsy is due to dysfunction of dominant BA6.
    Isella V; Licciardo D; Ferri F; Crivellaro C; Morzenti S; Appollonio I; Ferrarese C
    Front Aging Neurosci; 2022; 14():969875. PubMed ID: 36158541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcortical
    Cho H; Choi JY; Hwang MS; Lee SH; Ryu YH; Lee MS; Lyoo CH
    Mov Disord; 2017 Jan; 32(1):134-140. PubMed ID: 27813160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.